Updates on the Treatment Approach for MCL
What's the Difference? Covalent vs. Non-Covalent BTKis in MCL
By
Icahn School of Medicine at Mount Sinai
FEATURING
Joshua Brody
By
Icahn School of Medicine at Mount Sinai
FEATURING
Joshua Brody
This video was recorded prior to ibrutinib's withdrawal for the Mantle Cell Lymphoma indication on ...
read more ↘
read more ↘
Login to view comments.
Click here to Login
